Taxonomy and Clinical Spectra of Fusarium Species: Where Do We Stand in 2014?

Current Clinical Microbiology Reports

Volumn 1, Issue 1-2, 2014, Pages 10-18

  van Diepeningen, Anne D ^a   Al Hatmi, Abdullah M S ^a,b,c   Brankovics, Balázs ^a   de Hoog, G Sybren ^{a,b,d,e,f,g,h}  

^a CBS KNAW FUNGAL BIODIVERSITY CENTRE   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c MINISTRY OF HEALTH   (Oman)

^d PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^e SUN YAT SEN UNIVERSITY   (China)

^f SECOND MILITARY MEDICAL UNIVERSITY   (China)

^g FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^h KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Disseminated infection; Emerging fungal pathogen; Fusarioses; Fusarium avenaceum; Fusarium chlamydosporum; Fusarium dimerum species complex; Fusarium fujikuroi species complex; Fusarium incarnatum equiseti species complex; Fusarium lateritium; Fusarium oxysporum species complex; Fusarium semitectum; Fusarium solani species complex; Fusarium sporotrichioides; Incidence; Keratitis; Nomenclatural stability; Onychomycosis; Population studies

Indexed keywords

EID: 84978014015     PISSN: None     EISSN: 21965471     Source Type: Journal    
DOI: 10.1007/s40588-014-0003-x     Document Type: Review

References (96)

1. Hawksworth DL. A new dawn for the naming of fungi: impacts of decisions made in Melbourne in July 2011 on the future publication and regulation of fungal names. IMA Fungus. 2011;2:155–62.
2. Geiser DM, Aoki, Bacon CW, et al. One Fungus, One Name: Defining the genus Fusarium in a scientifically robust way that preserves longstanding use. Phytopathology. 2013;103(5):400–8. This paper sets the agreement to keep the name Fusarium a large genus, including all the clinical Fusarium species described in this paper.
3. De Hoog GS, Haase G, Chaturvedi V, Walsh TJ, Meyer W, Lackner M. Taxonomy of medically important fungi in the molecular era. The Lancet Infectious Diseases. 2013;13(5):385–6. Plea for more nomenclatural stability for clinically important species.
4. Taylor JW, Jacobson DJ, Kroken S, Kasuga T, Geiser DM, Hibbett DS, et al. Phylogenetic species recognition and species concepts in fungi. Fungal Genet Biol. 2000;31:21–32.
5. Short DP, O'Donnell K, Thrane U, et al. Phylogenetic relationships among members of the Fusarium solani species complex in human infections and the descriptions of F. keratoplasticum sp. nov. and F. petroliphilum stat. nov. Fungal Genet Biol. 2013;53:59–70.
6. O’Donnell K, Rooney AP, Proctor RH, et al. RPB1 and RPB2 phylogeny supports an early Cretaceous origin and a strongly supported clade comprising all agriculturally and medically important fusaria. Fungal Genet Biol. 2012. doi:10.1016/j.fgb.2012.12.004.
7. Leslie JF, Summerell BA. The Fusarium laboratory manual. Oxford: Blackwell Publishing Ltd; 2006.
8. De Hoog GS, Guarro J, Gené J, Figueras MJ. Atlas of Clinical Fungi. 3rd ed. Utrecht: CD-ROM, CBS-KNAW Fungal Biodiversity Centre; 2011.
9. O'Donnell K, Sutton DA, Rinaldi, et al. Internet-accessible DNA sequence database for identifying Fusaria from human and animal infections. Journal of Clinical Microbiology. 2010;48:3708–18.
10. Palmore TN, Shea YR, Childs RW, Sherry RM, Walsh TJ. Fusarium proliferatum soft tissue infection at the site of a puncture by a plant: recovery, isolation, and direct molecular identification. J Clin Microbiol. 2010;48(1):338–42.
11. Wang H, Xiao M, Kong F, et al. Accurate and practical identification of 20 Fusarium species by seven-locus sequence analysis and reverse line blot hybridization, and an in vitro antifungal susceptibility study. J Clin Microbiol. 2011;49(5):1890–8.
12. Niessen L, Vogel RF. Detection of Fusarium graminearum DNA using a loop-mediated isothermal amplification (LAMP) assay. Int J Food Microbiol. 2010;140(2–3):183–91.
13. Davari M, van Diepeningen AD, Babai-Ahari A, et al. Rapid identification of Fusarium graminearum species complex using Rolling Circle Amplification (RCA). J Microbiol Methods. 2012;89(1):63–70.
14. Buelow DR, Gu Z, Walsh TJ, Hayden RT. Evaluation of multiplexed PCR and liquid-phase array for identification of respiratory fungal pathogens. Med Mycol. 2012;50(7):775–80.
15. He D, Hao J, Zhang B, et al. Pathogenic spectrum of fungal keratitis and specific identification of Fusarium solani. Invest Ophthalmol Vis Sci. 2011;52(5):2804–8.
16. Lau A, Sorrell TC, Chen S, Stanley K, Iredell J, Halliday C. Multiplex tandem PCR: a novel platform for rapid detection and identification of fungal pathogens from blood culture specimens. J Clin Microbiol. 2008;46(9):3021–7.
17. Spiess B, Seifarth W, Hummel M, et al. DNA microarray-based detection and identification of fungal pathogens in clinical samples from neutropenic patients. J Clin Microbiol. 2007;45(11):3743–53.
18. Liao MH, Lin JF, Li SY. Application of a multiplex suspension array for rapid and simultaneous identification of clinically important mold pathogens. Mol Cell Probes. 2012;26(5):188–93.
19. De Carolis E, Posteraro B, Lass-Flörl C, et al. Species identification of Aspergillus, Fusarium and Mucorales with direct surface analysis by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Microbiol Infect. 2012;18(5):475–84.
20. Marinach-Patrice C, Lethuillier A, Marly A, et al. Use of mass spectrometry to identify clinical Fusarium isolates. Clin Microbiol Infect. 2009;15(7):634–42.
21. Seyfarth F, Ziemer M, Sayer HG, et al. The use of ITS DNA sequence analysis and MALDI-TOF mass spectrometry in diagnosing an infection with Fusarium proliferatum. Exp Dermatol. 2008;17(11):965–71.
22. Migheli Q, Balmas V, Harak H, et al. Molecular Phylogenetic Diversity of Dermatologic and Other Human Pathogenic Fusarial Isolates from Hospitals in Northern and Central Italy. J Clin Microbiol. 2010;48:1076–84.
23. Ninet B, Jan I, Bontems O, et al. Molecular identification of Fusarium species in onychomycoses. Dermatology. 2005;210:21–5.
24. Castro López N, Casas C, Sopo L, et al. Fusarium species detected in onychomycosis in Colombia. Mycoses. 2008;52:350–6.
25. Homa M, Shobana CS, Singh YR, et al. Fusarium keratitis in South India:causative agents, their antifungal susceptibilities and a rapid identification method for the Fusarium solani species complex. Mycoses. 2013;56:501–11.
26. Vanzzini Zago V, Manzano-Gayosso P, Hernández-Hernández F, Méndez-Tovar LJ, Gómez-Leal A, López MR. Queratomicosis en un centro de atención oftalmológica en la Ciudad deMéxico. Rev Iberoam Micol. 2010;27:57–61.
27. Lortholary O, Obenga G, Biswas P, et al. International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole. Antimicrob Agents Chemother. 2010;54:4446–50.
28. O’Donnell K, Sutton DA, Rinaldi MG, Gueidan C, Crous PW, Geiser DM. Novel Multilocus Sequence Typing Scheme Reveals High Genetic Diversity of Human Pathogenic Members of the Fusarium incarnatum-F. equiseti and F. chlamydosporum Species complexes within the United States. Journal of Clinical Microbiology. 2009;47:3851–61.
29. Ghannoum MA, Hajjeh RA, Scher R. A large scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns. J Am Acad Dermatol. 2000;43:641–8.
30. Ellis DH, Watson AB, Marley JE, Williams TG. Non-dermatophytes in onychomycosis of the toenails. Br J Dermatol. 1997;136:490–3.
31. Heikkilä H, Stubb S. The prevalence of onychomycosis in Finland. Br J Dermatol. 1995;133:699–703.
32. Girmenia C, Pagano L, Corvatta L, Mele L, del Favero A, Martino P. The epidemiology of fusariosis in patients with haematological diseases. Gimema Infection Programme. Br J Haematol. 2000;111(1):272–6.
33. Nucci M, Varon AG, Garnica M, et al. Increased incidence of invasive fusariosis with cutaneous portal of entry. Brazil Emerg Infect Dis. 2013;19(10):1567–72.
34. Nucci M, Garnica M, Gloria AB, et al. Invasive fungal diseases in haematopoietic cell transplant recipients and in patients with acute myeloid leukaemia or myelodysplasia in Brazil. Clin Microbiol Infect. 2013;19(8):745–51.
35. Guilhermetti E, Takahachi G, Shinobu CS, Svidzinski TI. Fusarium spp. as agents of onychomycosis in immunocompetent hosts. Int J Dermatol. 2007;46:822–6.
36. Banerji JS, Singh JC. Cutaneous Fusarium infection in a renal transplant recipient: a case report. J Med Case Reports. 2011;5:205.
37. Zapater RC. Opportunistic fungus infection – Fusarium infections –keratomycosis by Fusarium. Japanese Journal of Medical Mycology. 1986;27:68–9.
38. Hsiue HC, Ruan SY, Kuo YL, Huang YT, Hsueh PR. Invasive infections caused by non-Aspergillus moulds identified by sequencing analysis at a tertiary care hospital in Taiwan, 2000-2008. Clin Microbiol Infect. 2010;16:1204–6.
39. Vincent AL, Cabrero JE, Greene JN, Sandin RL. Successful voriconazole therapy of disseminated Fusarium solani in the brain of a neutropenic cancer patient. Cancer Control. 2003;10:414–9.
40. Guinvarc'h A, Guilbert L, Marmorat-Khuong A, et al. Disseminated Fusarium solani infection with endocarditis in a lung transplant recipient. Mycoses. 1998;1(1–2):59–61.
41. Park BJ, Pappas PG, Wannemuehler KA, et al. Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006. Emerg Infect Dis. 2011;17(10):1855–64. doi:10.3201/eid1710.110087.
42. Lodato F, Tamé MR, Montagnani M, et al. Systemic fungemia and hepatic localizations of Fusarium solani in a liver transplanted patient: an emerging fungal agent. Liver Transpl. 2006;12:1711–4.
43. Van Etta LL, Peterson LR, Gerding DN. Acremonium falciforme (Cephalosporium falciforme) mycetoma in a renal transplant patient. Arch Dermatol. 1983;119(8):707–8.
44. Yun SJ, Shin MG, Choi C, et al. Fatal disseminated angioinvasive Fusarium falciforme infection in a patient with acute myeloid leukaemia. Br J Dermatol. 2007;157(2):407–9.
45. Edupuganti S, Rouphael N, Mehta A, et al. Fusarium falciforme Vertebral Abscess and Osteomyelitis:Case Report and Molecular Classification. J Clin Microbiol. 2011;49:2350–3.
46. Summerbell RC, Schroers HJ. Analysis of phylogenetic relationship of Cylindrocarpon lichenicola and Acremonium falciforme to the Fusarium solani species complex and a review of similarities in the spectrum of opportunistic infections caused by these fungi. J Clin Microbiol. 2002;40(8):2866–75.
47. Short DPG, O’Donnell K, Thrane U, et al. Phylogenetic relationships among members of the Fusarium solani species complex in human infections and the descriptions of F. keratoplasticum sp. Nov. and F. petrophilum stat.nov. Fungal Genetics and Biology. 2013;53:59–70.
48. O'Donnell K, Sutton DA, Fothergill A, et al. Molecular phylogenetic diversity, multilocus haplotype nomenclature, and in vitro antifungal resistance within the Fusarium solani species complex. J Clin Microbiol. 2008;6:2477–90.
49. Iwen PC, Tarantolo SR, Sutton DA, Rinaldi MG, Hinrichs SH. Cutaneous infection caused by Cylindrocarpon lichenicola in a patient with acute myelogenous leukemia. Journal of Clinical Microbiology. 2000;38:3375–8.
50. Mangiaterra M, Giusiano G, Smilasky G, Zamar L, Amado G, Vincentín C. Keratomycosis caused by Cylindrocarpon lichenicola. Med Mycol. 2001;39:143–5.
51. Sharma R, Farmer CK, Gransden WR, Ogg CS. Peritonitis in continuous ambulatory peritoneal dialysis due to Cylindrocarpon lichenicola infection. Nephrology, Dialysis, Transplantation. 1998;13:2662–4.
52. James EA, Orchard K, McWhinney PH, et al. Disseminated infection due to Cylindrocarpon lichenicola in a patient with acute myeloid leukaemia. J Infect. 1997;34(1):65–7.
53. Assaf C, Goerdt S, Seibold M, Orfanos C. Clinical picture: Cutaneous hyalohyphomycosis. Lancet. 2000;356:1185.
54. Naiker S, Odhav B. Mycotic keratitis:profile of Fusarium species and their mycotoxins. Mycoses. 2004;47:50–6.
55. Krcmery Jr V, Jesenska Z, Spanik S, et al. Fungaemia due to Fusarium spp. in cancer patients. Journal of Hospital Infections. 1997;36:223–8.
56. García-Martos P, Gil de Sola F, Marín P, et al. Fungal peritonitis in ambulatory continuous peritoneal dialysis: description of 10 cases. Nefrologia. 2009;29:534–9. in Spanish.
57. Albisetti M, Lauener RP, Güngör T, Schär G, Niggli FK, Nadal D. Disseminated Fusarium oxysporum infection in hemophagocytic lymphohistiocytosis. Infection. 2004;32:364–6.
58. Durand-Joly I, Alfandari S, Benchikh Z, et al. Successful outcome of disseminated Fusarium infection with skin localization treated with Voriconazole and Amphotericin B-lipid complex in a patient with acute leukemia. J Clin Microbiol. 2004;41:4898–900.
59. Eljaschewitsch J, Sandfort J, Tintelnot K, Horbach I, Ruf B. Port-a-cath-related Fusarium oxysporum infection in an HIV-infected patient:treatment with liposomal amphotericin B. Mycoses. 1996;39(3–4):115–9.
60. Sturm AW, Grave W, Kwee WS. Disseminated Fusarium oxysporum infection in patient with heatstroke. Lancet. 1989;1(8644):968.
61. Schroers HJ, O'Donnell K, Lamprecht SC, et al. Taxonomy and phylogeny of the Fusarium dimerum species group. Mycologia. 2009;101:44–70.
62. Goldschmied-Reouven A, Friedman J, Block CS. Fusarium specie isolated from non-ocular sites:a 10-year experience at an Israeli general hospital. Journal de Mycologie Médicale. 1993;3:99–102.
63. Letscher-Bru V, Campos F, Waller J, Randriamahazaka R, Candolfi E, Herbrecht R. Successful outcome of treatment of a disseminated infection due to Fusarium dimerum in a Leukemia patient. J Clin Microbiol. 2002;40:1100–2.
64. Kiehn TE, Nelson PE, Bernard EM, Edwards FF, Koziner B, Armstrong D. Catheter-associated fungemia caused by Fusarium chlamydosporum in a patient with lymphocytic lymphoma. Journal of Clinical Microbiology. 1985;21:501–4.
65. Imwidthaya S, Chuntrasakul C, Chantarakul N. Opportunistic fungal infection of the burn wound. J Med Assoc Thai. 1984;67:242–8.
66. McGinnis MR, Severo LC, Kalil R, Faleiro PT. Endocarditis caused by Fusarium pallidoroseum. Journal de Mycologie Médicale. 1994;4:45–7.
67. Alastruey-Izquierdo A, Cuenca-Estrella M, Monzón A, Mellado E, Rodríguez-Tudela JL. Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods. Journal of Antimicrobial Chemotherapy. 2008;61:805–9.
68. Boutati EI, Anaissie EJ. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years’ experience at a cancer center and implications for management. Blood. 1997;90:999–1008.
69. Taj-Aldeen SD, Gene J, Al Bozom I, Buzina W, Cano JF, Guarro J. Gangrenous necrosis of the diabetic foot caused by Fusarium acutatum. Med Mycol. 2006;44:547–52.
70. Okuda C, Ito M, Sato Y, Oka K, Hotchi M. Disseminated cutaneous Fusarium infection with vascular invasion in a leukemic patient. Journal of Medical and Veterinary Mycology. 1987;25:177–86.
71. Kebabcı N, van Diepeningen AD, Ener B, et al. Fatal break-through infection with Fusarium andiyazi:new multi-resistant etiological agent cross-reacting with Aspergillus galactomannan enzyme immunoassay. Mycoses. 2013. doi:10.1111/myc.12142.
72. Lee SK, Kim SS, Nahm DH, et al. Hypersensitivity pneumonitis caused by Fusarium napiforme in a home environment. Allergy. 2000;55:1190–3.
73. Melcher GP, McGough DA, Fothergill AW, Norris C, Rinaldi MG. Disseminated hyalohyphomycosis caused by a novel human pathogen, Fusarium napiforme. Journal of Clinical microbiology. 1993;31:1461–7.
74. Bueno JG, Martinez C, Zapata B, Sanclemente G, Gallego M, Mesa AC. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis. Clinial and Experimental Dermatology. 2010;35:658–63.
75. Krulder JW, Brimicombe RW, Wijermans PW, Gams W. Systemic Fusarium nygamai infection in a patient with lymphoblastic non-Hodgkin's lymphoma. Mycoses. 1996;39:121–3.
76. Ferrer C, Alio J, Rodriguez A, Andreu M, Colom F. Endophthalmitis Caused by Fusarium proliferatum. Journal of Clinical Microbiology. 2005;43:5372–5.
77. Murray CK, Beckius ML, McAllister K. Fusarium proliferatum superficial suppurative thrombophlebitis. Military Medicine. 2003;168:426.
78. Summerbell RC, Richardson SE, Kane J. Fusarium proliferatum as an agent of disseminated infection in an immunosuppressed patient. Journal of clinical Microbiology. 1988;26:82–7.
79. Chander J, Singla N, Gulati N, Sood S. Fusarium sacchari:A cause of exogenous fungal endophthalmitis:First case report and review of literature. Mycopathologia. 2011;171:431–4.
80. Guarro J, Nucci M, Akiti T, et al. Fungemia due to Fusarium sacchari in an immunosuppressed patient. J Clin Microbiol. 2000;38:419–21.
81. Polenghi F, Lasagni A. Observations on a case of mycokeratitis and its treatment with BAY b 5097 (Canesten). Mykosen. 1976;19:223–6.
82. Chen QX, Li CX, Huang WM, Shi JQ, Li SF. Cutaneous hyalohyphomycosis caused by Fusarium subglutinans. European Journal of Dermatology. 2010;20:526–7.
83. Yücesoy M, Ergon MC, Oren H, Gülay Z. Case report:a Fusarium fungaemia. Mikrobiyol Bul. 2004;38:265–71. in Turkish.
84. Wang H, Xiao M, Kong F, Chen S, Dou HT, Sorrell T, et al. Accurate and practical identification of 20 Fusarium species by Seven-Locus Sequence Analysis and Reverse Line Blot Hybridization, and an in vitro antifungal susceptibility study. J Clin Microbiol. 2011;49:1890–9.
85. Ajello L, Padhye AA, Chandler FW, McGinnis MR, Morganti L, Alberici F. Fusarium moniliforme, a new mycetoma agent. Restudy of a European case. European Journal of Epidemiology. 1985;1:5–10.
86. Sampathkumar P, Paya CV. Fusarium infection after solid-organ transplantation. Clin Infect Dis. 2001;32(8):1237–40.
87. Varon AG, Nouer SA, Barreiros G, et al. Superficial skin lesions positive for Fusarium are associated with subsequent development of invasive fusariosis. J Infect. 2013. doi:10.1016/j.jinf.2013.08.011.
88. Tiribelli M, Zaja F, Filì C, et al. Endogenous endophthalmitis following disseminated fungemia due to Fusarium solani in a patient with acute myeloid leukemia. European Journal of Haematology. 2002;68:314–7.
89. Guarro J. Fusariosis, a complex infection caused by a high diversity of fungal species refractory to treatment. Eur. J. Clin. Microbiol. Infect. Dis. 2013 http://link.springer.com/article/10.1007%2Fs10096-013-1924-7.
90. O’Donnell K, Gueidan C, Sink S, et al. A two-locus DNA sequence database for typing plant and human pathogens within the Fusarium oxysporum species complex. Fungal Genetics and Biology. 2009;46:936–48.
91. Knutsen AK, Torp M, Holst-Jensen A. Phylogenetic analyses of the Fusarium poae, Fusarium sporotrichioides and Fusarium langsethiae species complex based on partial sequences of the translation elongation factor-1 alpha gene. Int J Food Microbiol. 2004;95(3):287–95.
92. Kano R, Maruyama H, Kubota M, Hasegawa A, Kamata H. Chronic ulcerative dermatitis caused by Fusarium sporotrichioides. Medical Mycology. 2011;49:303–5.
93. Özyurt M, Ardıç N, Turan K, et al. The isolation of Fusarium sporotrichioides from a diabetic foot wound sample and identification. Marmara Medical Journal. 2008;2:68–72.
94. Namitome K, Kano R, Sekiguchi M, et al. Isolation of Fusarium sp. from a claw of a dog with onychomycosis. Journal of Veterinary Medicine and Science. 2011;73:965–9.
95. Guarro J, Rubio C, Gené J, et al. Case of Keratitis Caused by an Uncommon Fusarium Species. Journal of Clinical Microbiology. 2003;41:5823–6.
96. Cambuim IIFN, Neves RP, de Queiroz LA, Magalhães OMC, Lima DMM. Fusarium lateritium (NEES) as an agent of fungemia in a patient infected with the human immunodeficiency virus (HIV). Brazilian Journal of Microbiology. 2007;38:285–6.